The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer

about

Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.

P2860

Q47228316-524E2C55-0782-4C4D-B974-6383A9CB9F3A

P2860

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer

Item

http://www.wikidata.org/entity/Q37530349

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Role of Transurethral Rese ...... Muscle-Invasive Bladder Cancer

@en

The Role of Transurethral Rese ...... uscle-Invasive Bladder Cancer.

@nl

type

Item

label

The Role of Transurethral Rese ...... Muscle-Invasive Bladder Cancer

@en

The Role of Transurethral Rese ...... uscle-Invasive Bladder Cancer.

@nl

prefLabel

The Role of Transurethral Rese ...... Muscle-Invasive Bladder Cancer

@en

The Role of Transurethral Rese ...... uscle-Invasive Bladder Cancer.

@nl

P1476

The Role of Transurethral Rese ...... Muscle-Invasive Bladder Cancer

@en

P2093

Amir H Lebastchi

http://www.w3.org/2001/XMLSchema#string

Christopher M Russell

http://www.w3.org/2001/XMLSchema#string

Daniel E Spratt

http://www.w3.org/2001/XMLSchema#string

Todd M Morgan

http://www.w3.org/2001/XMLSchema#string

Tudor Borza

http://www.w3.org/2001/XMLSchema#string

P2860

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.

RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.

Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database.

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.

Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist!

Trimodality treatment and selective organ preservation for bladder cancer.

Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).

P304

381-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/BLC-160076

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28035319

http://www.w3.org/2001/XMLSchema#string

P932

5181666

http://www.w3.org/2001/XMLSchema#string

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer

about

P2860

P2860

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932